The company says its machine learning approach could help flag cardiac amyloidosis from standard 12-lead ECGs, though experts ...

AliveCor has spent years battling with Apple over the market for consumer heart monitoring technology. Now it’s hoping to make its imprint on professional health care with its new device, which ...

HeartBeam (NASDAQ: BEAT) a medical technology company focused on transforming cardiac care by providing powerful ...

HeartBeam said its study data advances the scientific foundation supporting a planned indication expansion of its ECG device ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced it ...

Too often, the first sign of cardiovascular disease may be a major event like a heart attack, stroke or cardiac arrest. Now, researchers and clinicians at Mayo Clinic are using artificial intelligence ...

HeartBeam has received FDA clearance for its synthesized 12-lead ECG software, making it the first cable-free device of its kind for at-home arrhythmia assessment. The clearance followed a successful ...

The 12-lead ECG hasn't changed in a century. The algorithms reading it have. Three CEOs and one educator on whether doctors ...

HeartBeam (NASDAQ: BEAT) a medical technology company focused on transforming cardiac care by providing powerful cardiac ...